Skip to main content

Advertisement

Table 8 CSF total protein and CSF l-lactate

From: Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis

  Units Pattern I MS Pattern II + III MS Pattern II MS Pattern III MS AQP4-IgG+ NMO [48]
CSF TP elevated Patients 3/9 (33.3) 14/20 (70) 8/13 (61.5) 6/7 (85.7) n.d.
CSF TP elevated Samples 3/15 (20) 29/43 (67.4) 15/26 (57.7) 14/17 (82.4) 80/152 (52.6)
CSF TP, all LPs mg/L 375 (187–750; 15) 550 (168–1930; 43) 501 (168–1930; 26) 640 (260–1277; 17) 473 (198–3620; 147)
CSF TP, if elevated mg/L 724 (532–750; 3) 622 (470–1930; 29) 571 (471–1930; 15) 693 (470–1277; 14) 780 (45.4–3620; 68)
CSF TP, >750 mg/L mg/L 0/15 (0) 8/43 (18.6) 4/26 (15.4) 4/17 (23.5) 41/147 (28)
CSF lactate elevated Patients 2/8 (25) 6/14 (42.9) 5/11 (45.5) 1/3 (33.3) n.d.
CSF lactate elevated Samples 2/9 (22.2) 7/28 (25) 6/20 (30) 1/8 (12.5) 27/83 (32.5)
CSF lactate, all LPs mmol/L 1.3 (1.1–2.35; 11) 1.9 (0.8–3.3; 28) 1.85 (0.8–3.3; 20) 1.9 (1.36–2.9; 8) 1.97 (0.87–6.8; 80)
CSF lactate, if elevated mmol/L 2.175 (2–2.35; 2) 2.5 (2.2–3.3; 7) 2.4 (2.2–3.3; 6) 2.9 (2.9–2.9; 1) 2.9 (2.1–6.8; 27)
CSF lactate, >3 mmol/L mmol/L 0/11 (0) 1/28 (3.6) 1/20 (5) 0/8 (0) 27/80 (33.8)
  1. n.d. no data
  2. Concentrations are reported as medians; range and total sample numbers examined are given in brackets